Betamab ApS
CVR 40337326 · Private limited company (ApS) · Dissolved after voluntary liquidation
Betamab ApS is a Private limited company (ApS), founded on , based in Humlebæk. The company is registered in the industry forskning og eksperimentel udvikling indenfor bioteknologi. The company is no longer active (status: dissolved after voluntary liquidation). 2 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2020) shows equity of DKK 419k and a net result of DKK -1.4m.
Company details
- CVR number
- 40337326
- Status
- Dissolved after voluntary liquidation
- Company type
- Private limited company (ApS)
- Founded
- Ceased
- Address
- c/o Søren Mouritsen, Hørsholmvej 11
3050 Humlebæk - Municipality
- Fredensborg
- Industry
- Forskning og eksperimentel udvikling indenfor bioteknologi (721100)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 54k
- Auditor
- Dansk Revision Randers
- Audit opted out
- No
Warning signs
| Annual reports filed late | 1 of 2 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 56.5% |
| Current ratio | – |
| Moves (last 2 years) | 3 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 1 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2020 | 2019 |
|---|---|---|
| Gross profit | DKK -736k | DKK -343k |
| Net profit | DKK -1.4m | DKK -268k |
| Equity | DKK 419k | DKK -217k |
| Total assets | DKK 741k | DKK 211k |
| Cash | DKK 278k | – |
| Avg. employees | 0 | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Dansk Revision Randers.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2020 – 31 Dec 2020 | 210 | Late | |
| 11 Mar 2019 – 31 Dec 2019 | 183 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Morten Peter Meldal | ||
| Board | Søren Mouritsen | ||
| Board | Teit Eliot Johansen | ||
| Board | Morten Peter Meldal | ||
| Owner (33%) | Søren Mouritsen | ||
| Owner (33%) | Morten Peter Meldal | ||
| Owner (10%) | Jan Albert Nikolaisen | ||
| Owner (10%) | Jan Nikolaisen | ||
| Owner (33%) | Søren Mouritsen | ||
| Owner (33%) | Morten Peter Meldal | ||
| Owner (5%) | ALK-ABELLÓ A/S | ||
| Auditor | 18. juni 2024 P/S | ||
| Founder | Søren Mouritsen | ||
| Founder | Morten Peter Meldal | ||
| Founder | Jan Albert Nikolaisen |
The CEOs' other companies
Morten Peter Meldal – 1 other companies
- MPM HOLDING ApS Active
Address history (4 moves)
| c/o Søren Mouritsen, Hørsholmvej 11, 3050 Humlebæk | |
| c/o Søren Mouritsen, Sønderskovvej 16, 3460 Birkerød | |
| c/o Kemisk Institut. Bygn 01, rum 304. Køben, Universitetsparken 5, 3., 2100 København Ø | |
| Mosesvinget 78, 2400 København NV | |
| Kvæsthusgade 3C, 1. tv, 1251 København K |
Other companies at the same address
- GOTTLIEB HOLDING A/S Opløst
Similar companies in Fredensborg
- Idun Genomics IVS Allerød
- 2 BAC Holding IVS Allerød
Questions and answers about Betamab ApS
Has Betamab ApS gone bankrupt?
No, Betamab ApS is not registered as bankrupt in the CVR register. Its status is: dissolved after voluntary liquidation.
Who is the auditor of Betamab ApS?
Betamab ApS most recently used Dansk Revision Randers.
When was Betamab ApS founded?
Betamab ApS was founded on 11 March 2019.
What is the equity of Betamab ApS?
Equity was DKK 419k according to the annual report for the period ending 31 December 2020.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.